Locomotor, transport and information functions in human body systems are carried out by active media in autowave regimes! Any living organism is a (micro-macro-mega) hierarchy of autowave subsystems-an ensemble of loosely coupled subsystems of a simpler structure. From the highest levels of the hierarchy, Autowave Codes-Signals arrive, which determine the transitions of subsystems from one autowave regime to another Autowave interaction (of Complex Coherent Action). Autowave interaction is a process associated with the evolution and interaction of spatial and wave structures in the active media of the organism.
Chaos in organism functioning tells about health. Periodicity - Autowave reverberator may presage a disease - Autism Spectrum Disorder; Chaotic nature of oscillations in active media of physiological systems is more optimal for their vital functions than periodic one. Firstly, systems that function in chaotic regimes, can re-arrange themselves faster and easier in case of change of environmental conditions, i.e. the so called adaptive control is more easily implemented in them. Secondly, "spreading" of oscillations strength along comparatively wide frequency band takes place in chaotic regime.
When an organism is young and healthy, physiological systems show the elements of chaotic behavior, i.e. irregularity and chaotic dynamics are the extremely important characteristics of health. Decrease in changeability and appearance of stable periodicity of Autowave reverberator are often connected with Autism.
The main purpose is to study brain plasticity (the changes that occur in the brain through Autowave reverberator) in children with autism. Research suggests that during development, the brains of children may change in response to their Autowave reverberator differently than the brains of typically developing individuals. Investigators want to understand why and how this difference may contribute to the symptoms of autism spectrum disorder (ASD). In this study, the investigators will be examining the effects of non-invasive neuromodulation SQUED™ series 28.1 home-use for Treatment of Autowave reverberator of Autism.
Integrative Team World Organization of Medical Synergetics (WOMS) - collaborations between physicians and researchers with expertise in biostatistics, physics, mathematics, engineering, and computer science.
Clinical diagnosis of autism or related conditions.
Cerebral level of Natal Trauma - brain injury;
Cervical level of Natal Trauma - injury of vertebral;
Cerebral anoxia.
Peripheral blindness - precludes use of Image converter SQUED™ (iSQUED™).
Peripheral deafness - precludes use of Sound converter SQUED™ (sSQUED™).
Any implanted metal device - precludes use of Electromagnetic converter SQUED™ (eSQUED™).
Any implanted cardiac pacemaker - precludes use of Electromagnetic converter SQUED™ (eSQUED™).
Participants will be 1 month to 21 years of age, diagnosed with autism by independent clinicians and confirmed by formal assessment (e.g., CDI, ADOS, Bayley, Sensory Profile), and with receptive and expressive vocabulary levels of ≥ 3 years age-equivalent, as assessed by standardized measures. Additionally, the Autism Diagnostic Interview will be administered to caregivers in order to appropriately identify specific areas (regarding speech, language and cognition) in which participants are experiencing the most difficulty. The experimental group will consist of children (Infant, Child and Adolescent) with Autowave reverberators of Autism (n = 80): 1/2/3/4 armed/Left/Right\_Spiral Autowaves.
Cohort
Prospective
SQUED™ series 28.1 home-use
DeviceSemiconducting QUantum Excitonic Device - artifificial active medium, where the processes of self-organization lead to creation and converter of Autowaves energy. Some autowaves have the properties of quasi-particles!
SQUED™ software of patient
This will be administered by Presence of Clinical protocol CRF-SQUED™and creation Active medium SQUED™ for a patient.
Click on the lead sponsor to view all of their trials.
American Federation of Medical Synergetics
Lead sponsor
Clinic of Synergetics, Department of Neurology/Neuropsychology WOMS
Collaborator
Institute of Medical Synergetics, Department of Cognitive Neurology WOMS
Collaborator
Laboratory of Neurocomputational Active Media WOMS
Collaborator
SQUED, Inc., USA
Collaborator
Center of Synergetics, Universität Stuttgart, Germany
Collaborator
Ivan Franko National University of Lviv, Ukraine
Collaborator
Danylo Halytsky Lviv National Medical University
Collaborator
World Organization of Medical Synergetics
Collaborator
World Autism Center, American Federation of Medical Synergetics
Collaborator
